Brought to you by
Introduction
This course discusses common immune-mediated and idiosyncratic adverse drug reactions (ADRs) related to the top 200 drugs dispensed by U.S. community pharmacies and less commonly noted ADRs affecting oral tissues. In addition, uncommon, time-related (delayed), usually dose-related ADRs, i.e., carcinogenesis and teratogenesis, and some secondary ADRs are presented.
Please note this is Part II of a two-part series. Adverse Drug Reactions – Part I discusses common “on-target,” “off-target,” and (3) cytotoxic reactions related to the top 200 drugs dispensed by U.S. community pharmacies, and less common ADRs that relate to dental therapeutics and/or manifest in the head and neck area.
Conflict of Interest Disclosure Statement
Disclaimer: Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy.
Note: Registration is required to take test.
Educators only! Use this feature to create assignments for your students.
Syllabus: Clinical Pharmacology – A Review for Oral Healthcare Providers
The information in this 13-module syllabus is intended (1) to meet academic requirements for Dental Students, Dental Hygiene Students, and Dental Assistant Students related to clinical pharmacology; (2) to provide a framework for an in-service training program in oral healthcare settings; and (3) to serve as a resource for oral healthcare personnel wishing to review evidence-based information on specific topics related to clinical pharmacology. A PDF is also available for each of the modules that may serve as a convenient chairside resource.
Academy of General Dentistry (AGD) Submission
To have your "proof of completion" information automatically submitted to the AGD, make sure to add your AGD membership number in the field provided on the Share Your Test Score page. Allow at least 30 days for your credit transfer to appear in your AGD account.
NEW - Tennessee Licensees - Beginning October 11, 2018 dentalcare.com will submit your CE course information to CE Broker.
Note for Tennessee and Louisiana Licensees:
For your “proof of completion” to be electronically reported to CE Broker within 30 days of program completion, please add your Tennessee/Louisiana License number in the field provided on the “Share Your Test Score” page. If you are licensed in multiple states, please enter just your Tennessee/Louisiana License number.
Note for Florida Licensees:
For your “proof of completion” to be electronically reported to CE Broker within 30 days of program completion, please add your Florida License number in the field provided on the “Share Your Test Score” page. If you are licensed in multiple states, please enter just your Florida License number. For accurate submission into Florida CE Broker:
RELATED COURSES
The Procter & Gamble Company is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Concerns or complaints about a dental CE provider may be directed to the provider or to ADA CERP at:
http://www.ada.org/cerp
